Mason Street Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-14,963
Closed -$655K – 1369
2020
Q4
$655K Buy
14,963
+80
+0.5% +$3.01K 0.01% 1085
2020
Q3
$586K Buy
14,883
+1,640
+12% +$53K 0.01% 1035
2020
Q2
$418K Buy
13,243
+983
+8% +$36.7K 0.01% 1134
2020
Q1
$432K Hold
12,260
– – 0.01% 1038
2019
Q4
$596K Buy
12,260
+285
+2% +$13K 0.01% 1075
2019
Q3
$569K Buy
11,975
+350
+3% +$16.4K 0.01% 1052
2019
Q2
$499K Buy
11,625
+441
+4% +$17.1K 0.01% 1098
2019
Q1
$432K Buy
+11,184
New +$379K 0.01% 1179

Other funds holding CSII

Mason Street Advisors's CSII Position: Q1 2021 in Review

Mason Street Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2021, closing a stake of 14,963 shares — an estimated $655K sold.

Mason Street Advisors first reported a position in CSII in Q1 2019 and held it in 8 quarters. The position peaked at $655K in Q4 2020. 174 funds tracked by Wall St. Rank hold CSII as of Q1 2021.

  • Mason Street Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 14,963 Cardiovascular Systems, Inc. shares in Q1 2021, an estimated $655K.
  • Mason Street Advisors first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and held it in 8 quarters.
  • Mason Street Advisors's Cardiovascular Systems, Inc. position peaked at $655K in Q4 2020.
  • 174 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.